India to Turkey: Axitinib Export Trade Route
India has recorded 17 verified shipments of Axitinib exported to Turkey, representing a combined trade value of $8.9K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $526 USD. The leading Indian exporter is ROYAL MEDICAL PRIVATE LIMITED , which accounts for 36% of total export value with 5 shipments worth $3.2K USD. On the buying side, TO THE ORDER OF INVOICE RAISED is the largest importer in Turkey with $2.3K USD in purchases. The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED , ROYAL MEDICAL PRIVATE LIMITED, RIZLIFE HEALTHCARE — together control 77% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Turkey Axitinib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $8.9K USD. The route is dominated by ROYAL MEDICAL PRIVATE LIMITED , which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's axitinib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $526 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with axitinib's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.8%, placing it at rank #20 among India's top axitinib export destinations globally.
On the import side, key buyers of Indian axitinib in Turkey include TO THE ORDER OF INVOICE RAISED , TO THE ORDER OF INVOICE RAISED TO, K.S. ATLAS DIS TIC.LTD STI and 6 others. TO THE ORDER OF INVOICE RAISED is the single largest importer with 3 shipments valued at $2.3K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#20
- Annual growth+30.8%
- Demand growth+27.6%
- Regulatory ease77/100
Top 10 Indian Axitinib Exporters to Turkey
Showing top 10 of 5 Indian suppliers exporting Axitinib to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ROYAL MEDICAL PRIVATE LIMITED Avg $638 per shipment | 5 | $3.2K | 35.7% |
| 2 | ROYAL MEDICAL PRIVATE LIMITED Avg $612 per shipment | 4 | $2.4K | 27.4% |
| 3 | RIZLIFE HEALTHCARE Avg $414 per shipment | 3 | $1.2K | 13.9% |
| 4 | RMPL PHARMA LLP Avg $363 per shipment | 3 | $1.1K | 12.2% |
| 5 | RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED Avg $488 per shipment | 2 | $976 | 10.9% |
This table shows the top 10 of 5 Indian companies exporting axitinib to Turkey, ranked by total trade value. The listed exporters are: ROYAL MEDICAL PRIVATE LIMITED , ROYAL MEDICAL PRIVATE LIMITED, RIZLIFE HEALTHCARE , RMPL PHARMA LLP, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED. ROYAL MEDICAL PRIVATE LIMITED is the dominant supplier with 5 shipments worth $3.2K USD, giving it a 36% market share. The top 3 suppliers together account for 77% of the total trade value on this route.
Top 10 Axitinib Importers in Turkey
Showing top 10 of 9 known buyers in Turkey receiving Axitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian axitinib in Turkey include TO THE ORDER OF INVOICE RAISED , TO THE ORDER OF INVOICE RAISED TO, K.S. ATLAS DIS TIC.LTD STI , AL HASEM OTOMOTIV TICARET LIMITED S, TO THE ORDER OF INVOICE RAISED TO , among 9 total buyers. The largest importer is TO THE ORDER OF INVOICE RAISED , accounting for $2.3K USD across 3 shipments — representing 26% of all axitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF INVOICE RAISED | 3 | $2.3K | 26.0% |
| 2 | TO THE ORDER OF INVOICE RAISED TO | 2 | $1.5K | 17.0% |
| 3 | K.S. ATLAS DIS TIC.LTD STI | 3 | $1.2K | 13.9% |
| 4 | AL HASEM OTOMOTIV TICARET LIMITED S | 2 | $976 | 10.9% |
| 5 | TO THE ORDER OF INVOICE RAISED TO | 2 | $867 | 9.7% |
| 6 | TO THE ORDER OF INVOICE | 2 | $751 | 8.4% |
| 7 | NA | 1 | $700 | 7.8% |
| 8 | . | 1 | $337 | 3.8% |
| 9 | INVOICE RAISED TO | 1 | $226 | 2.5% |
Top 10 Axitinib Formulations Imported by Turkey
Showing top 10 of 10 product formulations shipped on the India to Turkey Axitinib route, ranked by trade value
Turkey imports a wide range of axitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — INLYBEST-5MG (28TAB) (AXITINIB TABLETS) — accounts for $1.9K USD across 4 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INLYBEST-5MG (28TAB) (AXITINIB TABLETS) | 4 | $1.9K | 21.2% |
| 2 | INLYBEST-5MG (28TAB) (AXITINIB TABLETS) | 2 | $1.5K | 17.0% |
| 3 | INLYBEST-5MG (AXITINIB TABLETS) (50 PACK | 1 | $1.3K | 14.5% |
| 4 | AXILIEVA(AXITINIB TAB 5 MG)BT NO.BAXT220 | 3 | $1.2K | 13.9% |
| 5 | INLYBEST-5MG 28TAB AXITINIB TABLETS | 2 | $926 | 10.4% |
| 6 | INLYBEST 5 MG -AXITINIB TABLETS 5 MG B | 1 | $646 | 7.2% |
| 7 | INLYBEST-5MG (28TAB) (AXITINIB) (30 VIALS) | 1 | $546 | 6.1% |
| 8 | INLYBEST 5MG (28 TAB) (AXITINIB) (15 PACKX28=420 TABS)NOS | 1 | $337 | 3.8% |
| 9 | INLYBEST 5 MG (AXITINIB TABLETS 5MG) | 1 | $330 | 3.7% |
| 10 | INLYBEST 5MG (28TAB) (AXITINIB) | 1 | $204 | 2.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 8 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's axitinib exports to Turkey are driven primarily by a handful of large-scale manufacturers. ROYAL MEDICAL PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED , ROYAL MEDICAL PRIVATE LIMITED, RIZLIFE HEALTHCARE — together account for 77% of total trade value on this route. The average shipment value of $526 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as inlybest-5mg (28tab) (axitinib tablets) and inlybest-5mg (axitinib tablets) (50 pack , suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF INVOICE RAISED is the largest importer with 3 shipments worth $2.3K USD — representing 26% of all axitinib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $8.9K
- Avg. Shipment
- $526
- Suppliers
- 5
- Buyers
- 9
- Transit (Sea)
- ~23 days
- Annual Growth
- +30.8%
Other Axitinib Routes
Unlock the Full India to Turkey Axitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 17 shipments on this route.
Frequently Asked Questions — India to Turkey Axitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Axitinib to Turkey?
The leading Indian exporters of Axitinib to Turkey are ROYAL MEDICAL PRIVATE LIMITED , ROYAL MEDICAL PRIVATE LIMITED, RIZLIFE HEALTHCARE . ROYAL MEDICAL PRIVATE LIMITED holds the largest market share at approximately 36% of total trade value on this route.
Q What is the total value of Axitinib exports from India to Turkey?
India exports Axitinib to Turkey worth approximately $8.9K USD across 17 recorded shipments. The average value per shipment is $526 USD.
Q Which ports does India use to ship Axitinib to Turkey?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 8 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Turkey for Axitinib?
The average transit time for Axitinib shipments from India to Turkey is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Turkey Axitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.8% with demand growth tracking at 27.6%. The route is ranked #20 among India's top Axitinib export destinations globally.
Q How many suppliers are active on the India to Turkey Axitinib route?
There are currently 5 active Indian suppliers exporting Axitinib to Turkey. The market is moderately concentrated with ROYAL MEDICAL PRIVATE LIMITED accounting for 36% of total shipment value.
Q Who are the main importers of Axitinib from India in Turkey?
The leading importers of Indian Axitinib in Turkey include TO THE ORDER OF INVOICE RAISED , TO THE ORDER OF INVOICE RAISED TO, K.S. ATLAS DIS TIC.LTD STI , AL HASEM OTOMOTIV TICARET LIMITED S, TO THE ORDER OF INVOICE RAISED TO . TO THE ORDER OF INVOICE RAISED is the largest buyer with 3 shipments worth $2.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Axitinib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 9 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 17 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists